LeadingAge’s vice president of legal affairs, Clarette Yen, shares the latest in the DEA’s rescheduling of medical marijuana to Schedule III under the Controlled Substances Act. Members can access for free on the LeadingAge Learning Hub.
LeadingAge’s vice president of legal affairs, Clarette Yen, shares the latest in the DEA’s rescheduling of medical marijuana to Schedule III under the Controlled Substances Act. Members can access for free on the LeadingAge Learning Hub.